Ginkgo Bioworks raises $1.6 billion in NYSE debut
In New York, Ginkgo Bioworks began trading on the New York Stock Exchange on Friday, September 17 under the ticker DNA. Debuting at around $15 billion, the SPAC deal raised an estimated $1.6 billion for the Boston-based synthetic biology company. The company reported $88 million in sales in the first half of 2021, tracking […]














